Dr Reddy’s and Prestige BioPharma collaborate to commercialise trastuzumab biosimilar
The license agreement grants Dr. Reddy's the exclusive rights to commercialize the proposed biosimilar in select countries in Latin America and Southeast Asia
The license agreement grants Dr. Reddy's the exclusive rights to commercialize the proposed biosimilar in select countries in Latin America and Southeast Asia
The Uteshiya facility, licensed by Healthium, will exclusively manufacture Healthium’s arthroscopy portfolio, including patented products in India and U.S.
Sputnik M is a new member of the Sputnik vaccines family
Fyarro is the first and only approved therapy for adults for the treatment of malignant PEComa in adults
The Indian medical devices industry has been in focus since the pandemic. From US $ 11 billion in 2020 it is expected to touch US $ 50 billion by 2025. Mehernosh Daruwalla, Founder and MD, Lotus Surgicals shares a perspective with Thomas C Thottathil on the opportunities in this sector
Featuring identity verification using artificial intelligence (AI), LabPort was designed to facilitate immediate results reporting for diagnostic testing even in high-volume, field-based testing environments
CStone granted the exclusive rights to Hengrui for research, development, registration, manufacturing, and commercialization of anti-CTLA-4 mAb CS1002 in the Greater China region
Sputnik Light has been authorised in more than 15 countries with the registration process ongoing in a further 30 countries
Since its inception, the company has either acquired or taken a majority stake in five companies
The applicants will only have to get their Good Manufacturing Practices certification validated every five years to retain their licence
Subscribe To Our Newsletter & Stay Updated